Related Party Transactions |
3 Months Ended |
|---|---|
Mar. 31, 2022 | |
| Related Party Transactions | |
| Related Party Transactions |
Note 4 — Related Party Transactions Effective June 1, 2021, the Company, InvaGen, Fortress and Journey Medical Corporation (“Journey”), a consolidated entity under Fortress, entered into a secondment agreement for a certain Avenue employee to be seconded to Journey. During the secondment, Journey will have the authority to supervise the Avenue employee and will reimburse the Company for the employee’s salary and salary-related costs. The term of this agreement lasted until the approval of IV tramadol by the FDA or until the employee’s services are needed again by the Company. This employee returned back to work for the Company on December 1, 2021 and did not perform any work for Journey during the three months ended March 31, 2022 and accordingly, the amounts reimbursable to Avenue were $0 for the three months ended March 31, 2022 and 2021, respectively. |